Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ONO-2020 by Ono Pharmaceutical for Neurodegenerative Diseases: Likelihood of Approval
ONO-2020 is under clinical development by Ono Pharmaceutical and currently in Phase I for Neurodegenerative Diseases. According to GlobalData, Phase...